Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Zvonimir
None
The Impact of Formal and Informal Institutions on Economic Growth
Regarding the Arab region, GDP per capita virtually stagnated for more than 20 years from 1980. During the same period, GDP per capita in the world's highly industrialized states further increased and the gap between the Middle East and North Africa (MENA) and the highly developed countries widened. However, the differences between Arab countries and the Western states exist not only economically. The countries also differ regarding their political, legal, and social systems. This work explains the differences in development on the basis of institutional economics. In addition to a general theoretical part, an empirical analysis demonstrates the effects of institutions on income, and a historical case study explains the divergent development paths of the Arab region and selected advanced economies.
War in the Balkans, 1991-2002
Armed conflict on the territory of the former Yugoslavia between 1991 and 2001 claimed over 200,000 lives, gave rise to atrocities unseen in Europe since the Second World War, and left behind a terrible legacy of physical ruin and psychological devastation. Unfolding against the background of the end of cold war bipolarity, the new Balkan wars sounded a discordant counterpoint to efforts to construct a more harmonious European order, were a major embarrassment for the international institutions deemed responsible for conflict management, and became a preoccupation for the powers concerned with restoring regional stability. After more than a decade of intermittent hostilities the conflict has been contained, but only as a result of significant external interventions and the establishment of a series of de facto international protectorates, patrolled by UN, NATO, and EU sponsored peacekeepers with open-ended mandates.
S-172
Over the past half century, opinion has been divided as to the role of Lee Harvey Oswald in the assassination of President John F Kennedy. The rumours began to spread almost immediately that the accused assassin may have been working for or was being manipulated by individuals involved with the United States Intelligence apparatus. The most tantalising piece of evidence came from none other than Congressman Gerald R Ford, who had served as a Warren Commission member in 1964. Ford revealed in his (co-written) 1965 book "Oswald: Portrait of the Assassin" that the FBI had an 'undercover agent' in Dallas at the time of the assassination and that that agent was none other than Lee Harvey Oswald, the alleged assassin of President Kennedy. The two most asked questions in the whole JFK assassination story remain unanswered: Who was Lee Harvey Oswald and what was his role on 22 November 1963? In this book Glenn B Fleming looks at these claims and presents a compelling case that all is not as we have been told about accussed assassin Lee Harvey Oswald.
Clinical Aspects of Electroporation
Electroporation is the forefront in tumor ablation. This book presents the basic principles and clinical applications of electroporation, including the latest research results and patient data. A comprehensive approach to the basic science behind the development of this ground-breaking technique and its introduction into clinical practice, the book discusses the entire spectrum of currently available reversible treatments, the emerging irreversible applications, and their impact on patient care. Clinical Aspects of Electroporation is the first book intended for clinicians on this extremely important and rapidly developing field.
Imaginative Communities
Americans are loud. Amsterdam equals sex, drugs, and rock & roll. Mexicans are lazy and Germans are boring, but punctual. Paris is romantic, Wuhan infectious, Ukrainians heroic, and New Zealand untouched. This is the way people around the world think about cities, regions and countries and the communities that live there; through cliches and stereotypes. It can be frustrating and hindering trade, diplomacy, investment, tourism, or talent attraction. Many believe that such image problems can be resolved with advertising campaigns, but the classic tourism promotion model is broken and insufficient. This book explains what works and what doesn’t when it comes to improving the reputation of cities, regions, and countries. It does so without the use of jargon and with reference to numerous case-studies. The book primarily aims to inspire readers and offer them a broad overview of an issue in modern society that is of interest and relevance to all of us: the reputation of our communities.
The New Egalitarianism
This book tackles one of the most pressing issues currently facing centre-left governments: social inequality. At a time when the traditional mechanisms of social cohesion have been undermined by greater individualism, the globalization of production, and the fragmentation of social life, the challenges posed by inequality are more pronounced than ever before. As communities and cultures become more complex, social solidarity and social justice can increasingly seem like impossible ideals. Bringing together original contributions from globally renowned thinkers such as Gosta Esping-Andersen, Saskia Sassen, Ulrich Beck and Anthony Giddens, as well as senior New Labour figures, the book offers...
Clio in the Balkans
None
Germany in Transit
Publisher description
Biosimilarity
Summary: The focus of this book is on how the U.S. FDA will approve biosimilar drugs, as learned from recent approvals by the FDA. Understanding the limitations of the statutory limits and non-inferiority testing are presented as tools to obviate patient trials and minimize testing of immunogenicity. An in-depth scientific, mathematical and statistical view of the tools required to establish biosimilarity of biological drugs of different complexity -- a must for every developer of biosimilars. Features: First comprehensive analysis based on new guidelines and approval packages of several biosimilars Presents the first approach to challenge FDA in reducing or eliminating any testing in patients. Provides a comprehensive understanding of the U.S. statutory requirements vis-a-vis the regulatory guidelines Provides model CQA and Analytical Similarity testing protocols for cytokines and monoclonal antibodies Allow creation of a fast-to-market pathway to develop biosimilars
